Lv71
5000 积分 2022-03-11 加入
Synergy of nodal factors in predicting recurrence after treatment of N1b papillary thyroid carcinoma
20天前
已关闭
Synergy of Nodal Factors in Predicting Recurrence After Treatment of N1b Papillary Thyroid Carcinoma
21天前
已关闭
Synergy of Nodal Factors in Predicting Recurrence After Treatment of N1b Papillary Thyroid Carcinoma Get access Arrow
21天前
已关闭
Synergy of Nodal Factors in Predicting Recurrence After Treatment of N1b Papillary Thyroid Carcinoma Get access Arrow
21天前
已关闭
Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer
21天前
已完结
BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients
21天前
已完结
Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness Get access Arrow
21天前
已完结
Effect and Interactions of BRAF on Lymph Node Metastasis in Papillary Thyroid Carcinoma With Hashimoto Thyroiditis Get access Arrow
21天前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
22天前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
22天前
已完结
皖公网安备34019202002308
